<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Brusatori M</submitter><funding>Community Foundation for Southeastern Michigan</funding><funding>NCRR NIH HHS</funding><funding>NIH, National Center for Research Resources</funding><funding>Paul Strauss Endowed Chair and Wayne State University SSIM Program</funding><funding>National Institutes of Health</funding><funding>Wayne State University</funding><pagination>271-281</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9060146</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(4)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>This study profiles ceramides extracted from visceral and subcutaneous adipose tissue of human subjects by liquid chromatography-mass spectrometry to determine a correlation with status of diabetes and gender.&lt;h4>Methods&lt;/h4>Samples of visceral and abdominal wall subcutaneous adipose tissue (n = 36 and n = 31, respectively) were taken during laparoscopic surgery from 36 patients (14 nondiabetic, 22 diabetic and prediabetic) undergoing bariatric surgery with a body mass index (BMI) >35 kg/m&lt;sup>2&lt;/sup> with ≥1 existing comorbidity or BMI ≥40 kg/m&lt;sup>2&lt;/sup> . Sphingolipids were extracted and analyzed using liquid chromatography-mass spectrometry.&lt;h4>Results&lt;/h4>After logarithm 2 conversion, paired analysis of visceral to subcutaneous tissue showed differential accumulation of Cer(d18:1/16:0), Cer(d18:1/18:0), and Cer(d18:1/24:1) in visceral tissue of prediabetic/diabetic female subjects, but not in males. Within-tissue analysis showed higher mean levels of ceramide species linked to insulin resistance, such as Cer(d18:1/18:0) and Cer(d18:1/16:0), in visceral tissue of prediabetic/diabetic patients compared with nondiabetic subjects and higher content of Cer(d18:1/14:0) in subcutaneous tissue of insulin-resistant female patients compared with prediabetic/diabetic males. Statistically significant differences in mean levels of ceramide species between insulin-resistant African American and insulin-resistant Caucasian patients were not evident in visceral or subcutaneous tissue.&lt;h4>Conclusions&lt;/h4>Analysis of ceramides is important for developing a better understanding of biological processes underlying type 2 diabetes, metabolic syndrome, and obesity. Knowledge of the accumulated ceramides/dihydroceramides may reflect on the prelipolytic state that leads the lipotoxic phase of insulin resistance and may shed light on the predisposition to insulin resistance by gender.</pubmed_abstract><journal>Journal of diabetes</journal><pubmed_title>Ceramide changes in abdominal subcutaneous and visceral adipose tissue among diabetic and nondiabetic patients.</pubmed_title><pmcid>PMC9060146</pmcid><funding_grant_id>S10RR027926</funding_grant_id><funding_grant_id>S10 RR027926</funding_grant_id><pubmed_authors>Seyoum B</pubmed_authors><pubmed_authors>Auner GW</pubmed_authors><pubmed_authors>Brusatori M</pubmed_authors><pubmed_authors>Tucker SC</pubmed_authors><pubmed_authors>Wood MH</pubmed_authors><pubmed_authors>Maddipati KR</pubmed_authors><pubmed_authors>Koya SK</pubmed_authors><pubmed_authors>Honn KV</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ceramide changes in abdominal subcutaneous and visceral adipose tissue among diabetic and nondiabetic patients.</name><description>&lt;h4>Background&lt;/h4>This study profiles ceramides extracted from visceral and subcutaneous adipose tissue of human subjects by liquid chromatography-mass spectrometry to determine a correlation with status of diabetes and gender.&lt;h4>Methods&lt;/h4>Samples of visceral and abdominal wall subcutaneous adipose tissue (n = 36 and n = 31, respectively) were taken during laparoscopic surgery from 36 patients (14 nondiabetic, 22 diabetic and prediabetic) undergoing bariatric surgery with a body mass index (BMI) >35 kg/m&lt;sup>2&lt;/sup> with ≥1 existing comorbidity or BMI ≥40 kg/m&lt;sup>2&lt;/sup> . Sphingolipids were extracted and analyzed using liquid chromatography-mass spectrometry.&lt;h4>Results&lt;/h4>After logarithm 2 conversion, paired analysis of visceral to subcutaneous tissue showed differential accumulation of Cer(d18:1/16:0), Cer(d18:1/18:0), and Cer(d18:1/24:1) in visceral tissue of prediabetic/diabetic female subjects, but not in males. Within-tissue analysis showed higher mean levels of ceramide species linked to insulin resistance, such as Cer(d18:1/18:0) and Cer(d18:1/16:0), in visceral tissue of prediabetic/diabetic patients compared with nondiabetic subjects and higher content of Cer(d18:1/14:0) in subcutaneous tissue of insulin-resistant female patients compared with prediabetic/diabetic males. Statistically significant differences in mean levels of ceramide species between insulin-resistant African American and insulin-resistant Caucasian patients were not evident in visceral or subcutaneous tissue.&lt;h4>Conclusions&lt;/h4>Analysis of ceramides is important for developing a better understanding of biological processes underlying type 2 diabetes, metabolic syndrome, and obesity. Knowledge of the accumulated ceramides/dihydroceramides may reflect on the prelipolytic state that leads the lipotoxic phase of insulin resistance and may shed light on the predisposition to insulin resistance by gender.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-04T19:42:19.476Z</modification><creation>2025-04-04T19:42:19.476Z</creation></dates><accession>S-EPMC9060146</accession><cross_references><pubmed>35470585</pubmed><doi>10.1111/1753-0407.13262</doi></cross_references></HashMap>